HDR Scholarship - Antipsychotic use and bone

Location

Barwon Health Campus

Research topic

Antipsychotics are among the most commonly used medications, and their use for schizophrenia and related conditions tends to be lifelong commencing in early adulthood. While there is emerging evidence that antipsychotics are noxious to bone, the extent of this risk, which agents are most implicated, and the pathways underlying this risk are poorly understood.

Project aim

To clarify operative mechanisms, we plan to investigate whether different antipsychotic agents influence human osteoclast and osteoblast differentiation and function in vitro, and embryonic bone formation and adult bone microstructure in vivo.

Important dates

Applications close 5pm, Friday 10 January 2020.

Benefits

This scholarship is available over 3 years.

Stipend of $27,596 per annum tax exempt (2019 rate)
Relocation allowance of $500-1500 (for single to family) for students moving from interstate or overseas

Eligibility criteria

To be eligible you must:

be a domestic candidate (domestic includes candidates with Australian Citizenship, Australian Permanent Residency or New Zealand Citizenship).
meet Deakin's PhD entry requirements
be enrolling full time and hold an honours degree (first class) or an equivalent standard master's degree with a substantial research component.

Please refer to the research degree entry pathways page for further information.